Cargando…

Pharmacokinetics of tulathromycin following administration to stocker cattle with remote delivery devices

Remote delivery devices (RDD) are used by some to administer antimicrobials (AM) to cattle when treatment by manual injection is logistically difficult. However, it is not clear that the pharmacokinetics (PK) of AM administered by RDD is comparable to that for AM administered by injection; thus, it...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivera, J Daniel, Woolums, Amelia R, Giguère, Steeve, Johnson, Joseph T, Lutz, Alexis G, Tipton, Paige N, Crosby, William B, Hice, Ivy, Thoresen, Merrilee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827394/
https://www.ncbi.nlm.nih.gov/pubmed/31583406
http://dx.doi.org/10.1093/jas/skz311
_version_ 1783465302523117568
author Rivera, J Daniel
Woolums, Amelia R
Giguère, Steeve
Johnson, Joseph T
Lutz, Alexis G
Tipton, Paige N
Crosby, William B
Hice, Ivy
Thoresen, Merrilee
author_facet Rivera, J Daniel
Woolums, Amelia R
Giguère, Steeve
Johnson, Joseph T
Lutz, Alexis G
Tipton, Paige N
Crosby, William B
Hice, Ivy
Thoresen, Merrilee
author_sort Rivera, J Daniel
collection PubMed
description Remote delivery devices (RDD) are used by some to administer antimicrobials (AM) to cattle when treatment by manual injection is logistically difficult. However, it is not clear that the pharmacokinetics (PK) of AM administered by RDD is comparable to that for AM administered by injection; thus, it is not certain that cattle treated by RDD experience equivalent AM effect. Fifteen crossbred beef steers (body weight [BW] = 302.5 ± 21.7 kg) were used in a three-way crossover study to determine the PK of tulathromycin following administration with RDD in the BQA injection triangle. Cattle were treated by each of three methods at 2.5 mg of tulathromycin per kg of BW with a 60 d washout period between treatments: 1) subcutaneous injection of tulathromycin (SC), 2) treatment by RDD delivered by air pump projector (AIR, Pneudart, Model 178B) at 4.5 m distance, and 3) treatment by RDD delivered by CO(2)-powered projector at 7.5 m (CO(2), Pneudart, Model 176B). Blood was collected prior to injection and at various points up to 552 h post-administration, pharmacokinetic data were analyzed as a mixed model using animal as a random effect and method of administration, order of administration, and their interaction as fixed effects. Plasma creatine kinase (CK) was measured before treatment and at 24 h after treatment to determine the degree of muscle injury resulting from each treatment. Three darts administered by AIR did not discharge (20%; 95% CI = 4% to 48%); and results from these steers were excluded from analysis. Maximum plasma concentration (718, 702.6, and 755.5 µg/mL for SC, AIR, and CO(2), respectively) and area under the concentration-time curve (17,885, 17,423, and 18,796 µg • h/mL for SC, AIR and CO, respectively) were similar and not significantly different between methods of administration. There was an effect of time (P = 0.0002), period (P = 0.0001), and interaction between method of administration and study period (P = 0.0210) on plasma concentration of CK. However, method of treatment (P = 0.6091), interaction between method and time (P = 0.6972), interaction between period and time (P = 0.6153), and 3-way interaction between method, period and time (P = 0.6804) were not different. Results suggest that PK of tulathromycin following delivery by RDD can be similar to subcutaneous injection; however, failure of RDD to discharge after delivery by some types of projectors can cause an important proportion of cattle to fail to receive drug as expected.
format Online
Article
Text
id pubmed-6827394
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68273942019-11-07 Pharmacokinetics of tulathromycin following administration to stocker cattle with remote delivery devices Rivera, J Daniel Woolums, Amelia R Giguère, Steeve Johnson, Joseph T Lutz, Alexis G Tipton, Paige N Crosby, William B Hice, Ivy Thoresen, Merrilee J Anim Sci Animal Health and Well-being Remote delivery devices (RDD) are used by some to administer antimicrobials (AM) to cattle when treatment by manual injection is logistically difficult. However, it is not clear that the pharmacokinetics (PK) of AM administered by RDD is comparable to that for AM administered by injection; thus, it is not certain that cattle treated by RDD experience equivalent AM effect. Fifteen crossbred beef steers (body weight [BW] = 302.5 ± 21.7 kg) were used in a three-way crossover study to determine the PK of tulathromycin following administration with RDD in the BQA injection triangle. Cattle were treated by each of three methods at 2.5 mg of tulathromycin per kg of BW with a 60 d washout period between treatments: 1) subcutaneous injection of tulathromycin (SC), 2) treatment by RDD delivered by air pump projector (AIR, Pneudart, Model 178B) at 4.5 m distance, and 3) treatment by RDD delivered by CO(2)-powered projector at 7.5 m (CO(2), Pneudart, Model 176B). Blood was collected prior to injection and at various points up to 552 h post-administration, pharmacokinetic data were analyzed as a mixed model using animal as a random effect and method of administration, order of administration, and their interaction as fixed effects. Plasma creatine kinase (CK) was measured before treatment and at 24 h after treatment to determine the degree of muscle injury resulting from each treatment. Three darts administered by AIR did not discharge (20%; 95% CI = 4% to 48%); and results from these steers were excluded from analysis. Maximum plasma concentration (718, 702.6, and 755.5 µg/mL for SC, AIR, and CO(2), respectively) and area under the concentration-time curve (17,885, 17,423, and 18,796 µg • h/mL for SC, AIR and CO, respectively) were similar and not significantly different between methods of administration. There was an effect of time (P = 0.0002), period (P = 0.0001), and interaction between method of administration and study period (P = 0.0210) on plasma concentration of CK. However, method of treatment (P = 0.6091), interaction between method and time (P = 0.6972), interaction between period and time (P = 0.6153), and 3-way interaction between method, period and time (P = 0.6804) were not different. Results suggest that PK of tulathromycin following delivery by RDD can be similar to subcutaneous injection; however, failure of RDD to discharge after delivery by some types of projectors can cause an important proportion of cattle to fail to receive drug as expected. Oxford University Press 2019-11 2019-10-04 /pmc/articles/PMC6827394/ /pubmed/31583406 http://dx.doi.org/10.1093/jas/skz311 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the American Society of Animal Science. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Animal Health and Well-being
Rivera, J Daniel
Woolums, Amelia R
Giguère, Steeve
Johnson, Joseph T
Lutz, Alexis G
Tipton, Paige N
Crosby, William B
Hice, Ivy
Thoresen, Merrilee
Pharmacokinetics of tulathromycin following administration to stocker cattle with remote delivery devices
title Pharmacokinetics of tulathromycin following administration to stocker cattle with remote delivery devices
title_full Pharmacokinetics of tulathromycin following administration to stocker cattle with remote delivery devices
title_fullStr Pharmacokinetics of tulathromycin following administration to stocker cattle with remote delivery devices
title_full_unstemmed Pharmacokinetics of tulathromycin following administration to stocker cattle with remote delivery devices
title_short Pharmacokinetics of tulathromycin following administration to stocker cattle with remote delivery devices
title_sort pharmacokinetics of tulathromycin following administration to stocker cattle with remote delivery devices
topic Animal Health and Well-being
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827394/
https://www.ncbi.nlm.nih.gov/pubmed/31583406
http://dx.doi.org/10.1093/jas/skz311
work_keys_str_mv AT riverajdaniel pharmacokineticsoftulathromycinfollowingadministrationtostockercattlewithremotedeliverydevices
AT woolumsameliar pharmacokineticsoftulathromycinfollowingadministrationtostockercattlewithremotedeliverydevices
AT gigueresteeve pharmacokineticsoftulathromycinfollowingadministrationtostockercattlewithremotedeliverydevices
AT johnsonjosepht pharmacokineticsoftulathromycinfollowingadministrationtostockercattlewithremotedeliverydevices
AT lutzalexisg pharmacokineticsoftulathromycinfollowingadministrationtostockercattlewithremotedeliverydevices
AT tiptonpaigen pharmacokineticsoftulathromycinfollowingadministrationtostockercattlewithremotedeliverydevices
AT crosbywilliamb pharmacokineticsoftulathromycinfollowingadministrationtostockercattlewithremotedeliverydevices
AT hiceivy pharmacokineticsoftulathromycinfollowingadministrationtostockercattlewithremotedeliverydevices
AT thoresenmerrilee pharmacokineticsoftulathromycinfollowingadministrationtostockercattlewithremotedeliverydevices